India
+48 22 854 10 70
How Pharma Companies Verify Suppliers in India
May 7, 2026Importing pharmaceuticals from India creates major opportunities for European companies, but it also comes with a level of operational and compliance risk that many businesses only discover once the cooperation has already started.
In many cases, everything looks correct at first. The supplier has certifications, export experience, product documentation and a professional online presence. The problem is that some of the most important issues only become visible during direct verification or an on-site visit to the manufacturing facility.
One of the most common issues is the gap between how a supplier presents itself commercially and how the business actually operates on a day-to-day basis.
This can involve differences in production scale, documentation standards, quality processes or the overall level of operational organisation. In some cases, companies presented as manufacturers turn out to operate mainly as intermediaries.
In the pharmaceutical sector, these details matter. They can later affect documentation consistency, regulatory compliance and the overall stability of the supply chain.
Why more companies are verifying suppliers locally?
A few years ago, many importers managed the entire sourcing process remotely through calls, emails and documentation exchange. Today, more companies want direct visibility before committing to larger orders or long-term cooperation.
Documents alone rarely show how a facility actually operates, how organised the production environment is, or whether the supplier is realistically prepared for European market requirements.
That is why more pharmaceutical companies are carrying out supplier verification in India before the first shipment or payment takes place.
What supplier verification usually includes?
At Valeris, we support companies during this stage by working directly with suppliers on the ground in India.
This may include:
- verification of the company’s operational activity
- on-site visits to production facilities
- assessment of production scale and organisation
- review of quality documentation processes
- verification of export readiness for the European market
- evaluation of consistency between commercial declarations and actual operations
The earlier risks are identified, the easier they are to manage
In pharmaceutical imports, many of the most expensive problems can be avoided long before the shipment leaves India.
The earlier a company verifies its supplier and operational processes, the easier it becomes to reduce delays, compliance issues and unnecessary pressure later in the import process.
ul. Tyniecka 27/2
02-615 Warszawa, Polska
KRS: 0000097522
REGON 011883175
NIP 5261063249
District Court for the capital city of Warsaw in Warsaw,
XIII Commercial Division of the National Court Register
Share capital – PLN 153 500.00
© 2026 Polfrost Internationale Spedition Sp. z o.o. | RODO / GDPR | Cookies - Privacy policy
Designed and Created by Trendmark.pxl
